Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells

  1. Emilie Battivelli
  2. Matthew S Dahabieh
  3. Mohamed Abdel-Mohsen
  4. J Peter Svensson
  5. Israel Tojal Da Silva
  6. Lillian B Cohn
  7. Andrea Gramatica
  8. Steven Deeks
  9. Warner C Greene
  10. Satish K Pillai
  11. Eric Verdin  Is a corresponding author
  1. Gladstone Institutes, United States
  2. University of California, San Francisco, United States
  3. Karolinska Institutet, Sweden
  4. The Rockefeller University, United States

Abstract

Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of latently infected cells. The 'shock and kill' approach to a cure proposes to eliminate this reservoir via transcriptional activation of latent proviruses, enabling direct or indirect killing of infected cells. Currently available latency-reversing agents (LRAs) have however proven ineffective. To understand why, we used a novel HIV reporter strain in primary CD4+ T cells and determined which latently infected cells are reactivatable by current candidate LRAs. Remarkably, none of these agents reactivated more than 5% of cells carrying a latent provirus. Sequencing analysis of reactivatable vs.non-reactivatable populations revealed that the integration sites were distinguishable in terms of chromatin functional states. Our findings challenge the feasibility of 'shock and kill', and suggest the need to explore other strategies to control the latent HIV reservoir.

Data availability

All sequencing data generated during this study are included in the Integration sites Source data file 1

Article and author information

Author details

  1. Emilie Battivelli

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Matthew S Dahabieh

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mohamed Abdel-Mohsen

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. J Peter Svensson

    Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5863-6250
  5. Israel Tojal Da Silva

    Laboratory of Molecular Immunology, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Lillian B Cohn

    Laboratory of Molecular Immunology, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3485-8692
  7. Andrea Gramatica

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Steven Deeks

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6371-747X
  9. Warner C Greene

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Satish K Pillai

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Eric Verdin

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    For correspondence
    EVerdin@buckinstitute.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3703-3183

Funding

Center for AIDS Research, University of California, San Francisco and Gladstone Institute of Virology and Immunology

  • Emilie Battivelli
  • Mohamed Abdel-Mohsen

National Institute of Dental and Craniofacial Research (5-31532)

  • Eric Verdin

California HIV/AIDS Research Program

  • Emilie Battivelli

Canadian Institutes of Health Research (201311MFE-321128-179658)

  • Matthew S Dahabieh

Svenska Forskningsrådet Formas (VR2015-02312)

  • J Peter Svensson

National Institute of Allergy and Infectious Diseases (R01Ai117864)

  • Eric Verdin

National Institute on Drug Abuse (1R01DA041742-01)

  • Eric Verdin

National Institute of Dental and Craniofacial Research (1R01DE026010-01)

  • Eric Verdin

National Institute of Allergy and Infectious Diseases (R21AI129636)

  • Mohamed Abdel-Mohsen

Cancerfonden (CAN2016/576)

  • J Peter Svensson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Battivelli et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,991
    views
  • 1,155
    downloads
  • 131
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emilie Battivelli
  2. Matthew S Dahabieh
  3. Mohamed Abdel-Mohsen
  4. J Peter Svensson
  5. Israel Tojal Da Silva
  6. Lillian B Cohn
  7. Andrea Gramatica
  8. Steven Deeks
  9. Warner C Greene
  10. Satish K Pillai
  11. Eric Verdin
(2018)
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells
eLife 7:e34655.
https://doi.org/10.7554/eLife.34655

Share this article

https://doi.org/10.7554/eLife.34655

Further reading

    1. Microbiology and Infectious Disease
    Li Zhang, Fen Hu ... Hang Yang
    Research Article

    Phage-derived peptidoglycan hydrolases (i.e. lysins) are considered promising alternatives to conventional antibiotics due to their direct peptidoglycan degradation activity and low risk of resistance development. The discovery of these enzymes is often hampered by the limited availability of phage genomes. Herein, we report a new strategy to mine active peptidoglycan hydrolases from bacterial proteomes by lysin-derived antimicrobial peptide-primed screening. As a proof-of-concept, five peptidoglycan hydrolases from the Acinetobacter baumannii proteome (PHAb7-PHAb11) were identified using PlyF307 lysin-derived peptide as a template. Among them, PHAb10 and PHAb11 showed potent bactericidal activity against multiple pathogens even after treatment at 100°C for 1 hr, while the other three were thermosensitive. We solved the crystal structures of PHAb8, PHAb10, and PHAb11 and unveiled that hyper-thermostable PHAb10 underwent a unique folding-refolding thermodynamic scheme mediated by a dimer-monomer transition, while thermosensitive PHAb8 formed a monomer. Two mouse models of bacterial infection further demonstrated the safety and efficacy of PHAb10. In conclusion, our antimicrobial peptide-primed strategy provides new clues for the discovery of promising antimicrobial drugs.

    1. Ecology
    2. Microbiology and Infectious Disease
    Tom Clegg, Samraat Pawar
    Research Article Updated

    Predicting how species diversity changes along environmental gradients is an enduring problem in ecology. In microbes, current theories tend to invoke energy availability and enzyme kinetics as the main drivers of temperature-richness relationships. Here, we derive a general empirically-grounded theory that can explain this phenomenon by linking microbial species richness in competitive communities to variation in the temperature-dependence of their interaction and growth rates. Specifically, the shape of the microbial community temperature-richness relationship depends on how rapidly the strength of effective competition between species pairs changes with temperature relative to the variance of their growth rates. Furthermore, it predicts that a thermal specialist-generalist tradeoff in growth rates alters coexistence by shifting this balance, causing richness to peak at relatively higher temperatures. Finally, we show that the observed patterns of variation in thermal performance curves of metabolic traits across extant bacterial taxa is indeed sufficient to generate the variety of community-level temperature-richness responses observed in the real world. Our results provide a new and general mechanism that can help explain temperature-diversity gradients in microbial communities, and provide a quantitative framework for interlinking variation in the thermal physiology of microbial species to their community-level diversity.